Recombinant Acanthamoeba polyphaga mimivirus Cytochrome P450-like protein L532 (MIMI_L532)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Acanthamoeba polyphaga mimivirus Cytochrome P450-like protein L532 (MIMI_L532)

Recombinant Acanthamoeba polyphaga mimivirus Cytochrome P450-like protein L532, referred to here as MIMI_L532, is a protein of interest due to its association with the giant virus Acanthamoeba polyphaga mimivirus. This virus is notable for infecting Acanthamoeba species, which are opportunistic human pathogens . The presence of cytochrome P450-like proteins in viruses is unusual and has sparked research into their potential functions and evolutionary origins.

Background on Cytochrome P450 Proteins

Cytochrome P450 proteins are a large family of enzymes known for their role in metabolizing a wide range of substances, including drugs and steroids. They are typically found in eukaryotic organisms but have also been identified in some bacteria and viruses. The discovery of cytochrome P450 genes in the Acanthamoeba polyphaga mimivirus genome highlights the complexity and diversity of viral genomes .

Characteristics of MIMI_L532

MIMI_L532 is part of the cytochrome P450 family but lacks clear functional homology to known P450 enzymes. It is characterized by its unique structure and potential for novel functions, distinct from typical cytochrome P450 enzymes involved in steroid metabolism . The protein's function and the role it plays in the viral lifecycle remain largely unknown and require further investigation.

Table 1: Characteristics of MIMI_L532 and Related Proteins

ProteinHomologyFunctionExpression System
MIMI_L532UnknownUnknownE. coli (Potential)
YP_143162Low homology to CYP51No activity against 14-methyl sterolsE. coli
CYP51Sterol 14-demethylaseMetabolizes sterolsVarious eukaryotes

Implications and Future Research Directions

The study of MIMI_L532 and other viral cytochrome P450-like proteins offers insights into viral evolution and potential novel enzymatic functions. Future research should focus on elucidating the biological roles of these proteins, their interaction with host cells, and their potential applications in biotechnology or medicine.

Table 2: Potential Applications and Research Directions

Area of ResearchPotential Applications
BiotechnologyNovel enzymatic activities for industrial processes
MedicineUnderstanding viral-host interactions for therapeutic targets
Evolutionary BiologyInsights into viral genome evolution and adaptation

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during the production process. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
MIMI_L532; Cytochrome P450-like protein L532
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-468
Protein Length
full length protein
Species
Acanthamoeba polyphaga mimivirus (APMV)
Target Names
MIMI_L532
Target Protein Sequence
MVLSDILFSIYEHREKSPVFSWFAYLLRILDWIIQFLSFGLIPSIGGDLYDLVDNGLFKF VLDRNIQKKQNQLYDKFRLGTVKMCLVFDGELTKKLLLDNSIRRGGLYNLLTKFFGKGIF TSNIHSRWMKQRKAIFKLFSPQNLIQITPELTTSMFEELDRLITIKKDLDLVTVLSLIGL VGFCKVIFGVDVTDMSEELIEPLNDLLIYINGAVEPVLITADPSYRRFITNKKFVHNWMR KLIDKARKSENCFEIMRQQLDDIGSDDETELIEFILSVVLGGHETTARLMLGIIYSVCHN KEIIEKLNNETDEYPKGDYINLKKRPYLNNIIKEGTRLFPPVWLLSREAKNDTTIDNHFF KKGTQFLISPLIILRDYNVWGSNAEKFDPERFSNMDPKSKASKLYIPFIVGSEDCPGKKF AILESAIVVSKLFKEYEITVLKHKLNPMSAGTFRLSDKLPVSIKKLKN
Uniprot No.

Target Background

Protein Families
Cytochrome P450 family
Subcellular Location
Host membrane; Multi-pass membrane protein. Virion.

Q&A

What is MIMI_L532 and why is it significant to virology research?

MIMI_L532 (YP_142886) is one of two putative cytochrome P450 enzymes encoded in the Acanthamoeba polyphaga mimivirus genome. Its significance stems from being part of the first discovery of P450 enzymes in viral genomes. Mimivirus, with its 1.2-Mbp genome encoding 911 proteins, represents a unique evolutionary position that challenges traditional boundaries between viruses and cellular organisms. The presence of CYP genes in mimivirus is particularly intriguing from an evolutionary perspective, as P450 enzymes are thought to have existed in life forms for billions of years, potentially preceding free atmospheric oxygen .

The discovery of CYP genes in the mimivirus genome raises fundamental questions about horizontal gene transfer and the ancient origins of this enzyme family. Research into MIMI_L532 may provide insights into both viral evolution and the ancestral functions of cytochrome P450 enzymes before their specialization in oxygen-dependent reactions .

How does MIMI_L532 differ from the other mimivirus cytochrome P450 (MIMI_L808)?

MIMI_L532 (YP_142886) and MIMI_L808 (YP_143162) represent two distinct putative P450 enzymes in the mimivirus genome with different evolutionary relationships:

FeatureMIMI_L532 (YP_142886)MIMI_L808 (YP_143162)
Length468 amino acids709 amino acids
HomologyShows homology to bacterial P450 proteins (C. aurantiacus, 23% identity) and nematode P450 proteins (C. briggsae CYP37B1, 25% identity)Shows weak homology to CYP51 proteins from various organisms (21-23% identity)
StructureStandard P450 structureContains C-terminal extension with unknown function
Expression successDifficult to express as correctly folded proteinSuccessfully expressed with N-terminal modification
CYP designationCYP5254A1CYP5253A1
Functional characterizationNot yet characterizedCharacterized but function still unknown

While MIMI_L808 has been successfully expressed and characterized through spectroscopic analysis, attempts to express MIMI_L532 have been unsuccessful despite various experimental approaches .

What are the predicted structural features of MIMI_L532?

While direct structural characterization of MIMI_L532 remains challenging due to expression difficulties, computational analysis and comparison with related P450 enzymes suggest several structural features. As a cytochrome P450, MIMI_L532 is predicted to contain:

  • A heme-binding domain with a conserved cysteine residue that coordinates to the heme iron

  • The characteristic P450 fold with alpha helices and beta sheets

  • Substrate recognition sites that may differ from other P450 enzymes

  • Potential membrane-binding regions that could affect expression and solubility

Computational modeling approaches using homology to bacterial P450s may provide preliminary structural insights, though experimental validation through X-ray crystallography or cryo-EM would be necessary for definitive structural characterization .

What strategies have been attempted for MIMI_L532 expression and what were the challenges?

Multiple expression strategies have been attempted for MIMI_L532, all encountering significant challenges:

Expression StrategyOutcomeChallenge
Full-length expression in E. coliMisfolded protein (420 nm peak)Potential membrane-binding domains interfering with proper folding
Varied temperature conditionsUnsuccessfulContinued misfolding issues
Co-expression with chaperones (GroES/GroEL)UnsuccessfulFailed to correct folding problems
Different E. coli strainsUnsuccessfulHost limitations in processing viral proteins
N-terminal modification strategyNot reported for MIMI_L532Strategy that worked for MIMI_L808 not yet applied or unsuccessful

The consistent production of misfolded protein (indicated by the 420 nm peak rather than the characteristic 450 nm peak in CO-difference spectroscopy) suggests fundamental challenges with this protein's expression in heterologous systems. Unlike MIMI_L808, which was successfully expressed after N-terminal modification, MIMI_L532 may require alternative approaches or expression systems .

How might eukaryotic expression systems improve MIMI_L532 production?

While bacterial expression attempts have been unsuccessful, eukaryotic expression systems might offer advantages for MIMI_L532 production:

  • Insect cell expression systems: Baculovirus-infected insect cells provide eukaryotic protein processing machinery and membrane structures that may facilitate proper folding of MIMI_L532. The system allows for:

    • Post-translational modifications not available in bacterial systems

    • Better membrane protein expression

    • Controlled induction and expression conditions

  • Yeast expression systems (S. cerevisiae or P. pastoris):

    • Compatibility with membrane proteins

    • Established protocols for P450 expression

    • Potential for high-yield production through fermentation

  • Mammalian cell expression:

    • HEK293 or CHO cells for complex protein expression

    • Advanced folding and processing machinery

    • Options for transient or stable expression

Methodological approaches should include optimization of codon usage, signal peptides, and fusion tags specifically designed for eukaryotic expression. Temperature optimization, expression kinetics monitoring, and detergent screening would be critical experimental parameters to explore .

What purification approaches are recommended for viral cytochrome P450 enzymes like MIMI_L532?

Purification of viral cytochrome P450 enzymes presents unique challenges requiring specialized approaches:

  • Initial extraction and solubilization:

    • Determine membrane association through fractionation experiments

    • Optimize detergent screening (CHAPS, DDM, Triton X-100) for solubilization

    • Consider nanodiscs or amphipols for stabilization

  • Chromatographic purification strategy:

    Purification StepTechniqueConsiderations
    Initial captureImmobilized metal affinity chromatography (IMAC)Requires His-tag or similar fusion
    Intermediate purificationIon exchange chromatographyBuffer optimization critical
    PolishingSize exclusion chromatographyAssess oligomeric state
    Specialized techniquesAffinity chromatography using heme-binding propertiesMay increase specific activity
  • Quality assessment:

    • Spectroscopic analysis (CO-difference spectrum for correctly folded P450)

    • SDS-PAGE and western blotting

    • Mass spectrometry for confirmation

    • Thermostability assays to optimize buffer conditions

Throughout purification, it's critical to monitor the integrity of the heme cofactor using spectroscopic methods and to maintain reducing conditions to prevent oxidative damage. Based on experience with other viral proteins, inclusion of stabilizing agents like glycerol (10-20%) and reducing agents may improve protein stability during purification .

What experimental approaches can determine the substrate specificity of MIMI_L532?

Determining substrate specificity for an uncharacterized viral P450 like MIMI_L532 requires a systematic approach:

  • Spectral binding assays:

    • Type I shift (substrate binding) monitoring at 385-390 nm

    • Type II shift (inhibitor binding) monitoring at 425-435 nm

    • High-throughput screening of compound libraries

    • Measurement of binding constants (Ks) for potential substrates

  • Substrate screening strategies:

    • Host lipid metabolites from Acanthamoeba polyphaga

    • Common P450 substrates from different classes (sterols, fatty acids, xenobiotics)

    • Viral metabolic intermediates

    • Computational docking to identify potential ligands

  • Activity assays:

    • NADPH consumption assays to detect enzymatic turnover

    • Product formation analysis using LC-MS/MS

    • Oxygen consumption measurements

    • Reconstituted systems with different redox partners

  • Comparison with homologous systems:

    • Parallel analysis with bacterial P450s showing sequence similarity

    • Evaluation of activities observed in nematode homologs (CYP37B1)

Given the unusual evolutionary position of viral P450s, it may be necessary to consider non-traditional substrates and reaction types beyond the typical monooxygenase activity associated with most P450 enzymes .

How can redox partner systems be identified for MIMI_L532?

The functionality of cytochrome P450 enzymes depends on appropriate redox partners for electron transfer. For MIMI_L532, the identification of compatible redox partners presents a particular challenge:

  • Analysis of mimivirus genome:

    • Search for putative ferredoxin/ferredoxin reductase systems

    • Identify potential cytochrome P450 reductase-like proteins

    • Evaluate non-conventional electron transfer systems

  • Heterologous redox partner testing:

    • Bacterial systems (putidaredoxin/putidaredoxin reductase)

    • Mitochondrial systems (adrenodoxin/adrenodoxin reductase)

    • Microsomal system (NADPH-cytochrome P450 reductase)

    • Engineered fusion proteins with reductase domains

  • Host-derived electron transfer systems:

    • Investigation of Acanthamoeba redox proteins

    • Analysis of potential "borrowing" of host electron transfer machinery

  • Experimental validation methods:

    • Reconstitution experiments with purified components

    • Activity assays measuring NADPH consumption

    • Spectroscopic monitoring of electron transfer

    • Direct protein-protein interaction studies (SPR, ITC)

The absence of conventional redox partners in the mimivirus genome suggests either a novel electron transfer mechanism or reliance on host cellular machinery. Both possibilities should be systematically investigated .

What computational approaches can predict potential functions of MIMI_L532?

Computational methods offer valuable tools for predicting potential functions of uncharacterized proteins like MIMI_L532:

Given the low sequence identity to characterized P450s, computational predictions should be treated as hypotheses requiring experimental validation .

What evolutionary hypotheses explain the presence of cytochrome P450 genes in mimivirus?

Two competing hypotheses explain the presence of cytochrome P450 genes in the mimivirus genome:

  • Ancient origin hypothesis:

    • P450 enzymes existed before the advent of free atmospheric oxygen

    • Mimivirus and other giant viruses are very old, possibly predating cellular organisms

    • Viral P450s may represent ancient forms of these enzymes

    • This hypothesis suggests MIMI_L532 is a remnant of early enzyme evolution

  • Horizontal gene transfer hypothesis:

    • Mimivirus acquired P450 genes from endosymbionts or hosts

    • Acanthamoeba polyphaga hosts bacterial endosymbionts including Mycobacteria with numerous CYP genes

    • The mimivirus's complex replication cycle provides opportunities for gene acquisition

    • The low sequence identity (21-25%) to known P450s suggests ancient transfer or significant divergence

These hypotheses can be tested through advanced phylogenetic analysis, identification of genomic signatures of horizontal transfer, and comparative analysis of codon usage and GC content patterns across mimivirus and potential gene donors .

How might MIMI_L532 contribute to mimivirus-host interactions?

The potential role of MIMI_L532 in mimivirus-host interactions can be examined from several perspectives:

  • Host metabolism modulation:

    • Potential modification of host lipids or sterols

    • Alteration of signaling molecules within Acanthamoeba

    • Detoxification of host defense compounds

    • Production of mimivirus-specific metabolites

  • Viral replication cycle support:

    • Involvement in viral factory formation within host cells

    • Modification of viral structural components

    • Regulation of viral-host membrane interactions

    • Potential role in virion assembly or maturation

  • Experimental approaches to test interactions:

    • Gene knockout or silencing studies

    • Temporal expression analysis during infection cycle

    • Localization studies using fluorescent tagging

    • Metabolomics comparison of wild-type and mutant infections

  • Host range implications:

    • Potential contribution to host specificity

    • Adaptation to different amoeba species

    • Role in environmental persistence

Understanding MIMI_L532's function in host interaction requires integrated approaches combining transcriptomics, proteomics, and metabolomics throughout the viral infection cycle .

What are the implications of viral P450s for understanding P450 evolution?

The discovery of P450 enzymes in viruses has profound implications for understanding the evolution of this enzyme superfamily:

  • Re-evaluation of P450 evolutionary timeline:

    • Traditional view: P450s evolved in prokaryotes and diversified in eukaryotes

    • Viral P450 evidence: May push origin further back or suggest alternative evolutionary paths

    • Opportunity to study potentially ancient P450 forms preserved in viral genomes

  • Functional evolution analysis:

    • Original functions of P450 enzymes before oxygen-dependent chemistry

    • Potential for novel reaction chemistry in viral P450s

    • Evolutionary constraints in viral genome context

  • Comparative structural analysis opportunities:

    • Viral P450s may represent minimalist functional units

    • Identification of essential vs. dispensable P450 structural elements

    • MIMI_L532's bacterial-like homology vs. MIMI_L808's CYP51-like homology provides natural comparison

  • Horizontal gene transfer dynamics:

    • Viruses as potential vectors for P450 gene distribution

    • Role in accelerating P450 diversification

    • Contribution to host adaptation through acquired metabolic functions

Studying viral P450s like MIMI_L532 provides a unique window into both ancient enzyme functions and novel evolutionary mechanisms that may have shaped the entire P450 superfamily .

What specialized spectroscopic techniques can characterize MIMI_L532?

Advanced spectroscopic techniques provide powerful tools for characterizing MIMI_L532 structure and function:

  • Electronic absorption spectroscopy:

    • Baseline characterization of heme environment

    • Substrate binding studies through spectral shifts

    • Reduced CO-difference spectrum to confirm proper folding

    • Reduced absolute spectrum to assess heme coordination state

  • Electron paramagnetic resonance (EPR) spectroscopy:

    • Characterization of the ferric heme iron spin state

    • Detection of substrate-induced spin state changes

    • Identification of unusual coordination environments

    • Temperature-dependent measurements for detailed electronic structure

  • Resonance Raman spectroscopy:

    • Direct probing of the heme-thiolate coordination

    • Detection of substrate-induced heme conformational changes

    • Characterization of Fe-O2 intermediates

    • Comparison with bacterial P450 homologs for structural insights

  • Nuclear magnetic resonance (NMR):

    • Structural analysis of the properly folded protein

    • Substrate binding site mapping

    • Dynamics and conformational changes upon substrate binding

    • Potential for paramagnetic NMR to probe the active site

These techniques would be particularly valuable for comparing MIMI_L532 with MIMI_L808 to understand the structural diversity within viral P450s and their relationship to bacterial and eukaryotic homologs .

How can protein engineering approaches improve MIMI_L532 expression and stability?

Protein engineering offers several strategies to overcome the challenges of MIMI_L532 expression and stability:

  • N-terminal engineering:

    • Systematic truncation to remove membrane-binding domains

    • Addition of solubility-enhancing tags (MBP, SUMO, GST)

    • Signal sequence optimization for targeted expression

    • N-terminal modifications similar to those successful for MIMI_L808

  • Directed evolution approaches:

    • Error-prone PCR to generate expression-optimized variants

    • DNA shuffling with homologous bacterial P450s

    • Focused mutagenesis of problematic regions

    • Selection systems for properly folded variants

  • Rational design strategies:

    • Surface charge engineering to improve solubility

    • Disulfide bond introduction for stability

    • Glycine scanning to identify flexibility hotspots

    • Consensus-based design using bacterial homologs

  • Engineering outcomes prediction:

    Engineering StrategySuccess ProbabilityImplementation ComplexityExpected Improvement
    N-terminal modificationsHighLowExpression yield
    Fusion proteinsMedium-HighLowSolubility
    Surface charge engineeringMediumMediumStability
    Directed evolutionMediumHighMultiple parameters

Learning from the successful expression of MIMI_L808 after N-terminal modification suggests similar approaches may be valuable starting points for MIMI_L532 .

What in situ approaches can elucidate MIMI_L532 function during mimivirus infection?

Understanding MIMI_L532 function within the context of mimivirus infection requires sophisticated in situ approaches:

  • Advanced microscopy techniques:

    • Super-resolution microscopy to localize MIMI_L532 during infection

    • Correlative light and electron microscopy (CLEM) to relate function to viral structures

    • Live-cell imaging with fluorescently tagged MIMI_L532

    • FRET-based approaches to identify interaction partners

  • Genetic manipulation strategies:

    • CRISPR-Cas9 editing of the mimivirus genome to knockout MIMI_L532

    • Creation of reporter constructs to monitor expression timing

    • Complementation studies with modified MIMI_L532 variants

    • Conditional expression systems to control timing of expression

  • Functional genomics approaches:

    • RNA-Seq analysis of host response to wild-type vs. MIMI_L532 knockout

    • Ribosome profiling to assess translational regulation

    • ChIP-Seq to identify potential regulatory interactions

    • Proteomics to identify interaction partners during infection

  • Metabolic analysis:

    • Untargeted metabolomics to identify altered metabolites

    • Stable isotope labeling to track metabolic flux changes

    • Activity-based protein profiling for functional characterization

    • In situ enzymatic activity monitoring

These approaches could reveal the temporal and spatial aspects of MIMI_L532 function within the complex mimivirus replication cycle and provide insights not attainable through in vitro studies alone .

What emerging technologies will advance MIMI_L532 research?

Several cutting-edge technologies hold promise for advancing MIMI_L532 research:

  • Cryo-electron microscopy (cryo-EM):

    • High-resolution structural determination without crystallization

    • Visualization of MIMI_L532 in different conformational states

    • Integration into viral structural complexes

    • Analysis of membrane interactions

  • AI-powered structural prediction and function inference:

    • AlphaFold2 and RoseTTAFold for accurate structural models

    • Machine learning algorithms to predict function from structure

    • Integration of evolutionary and structural data

    • Virtual screening of large compound libraries

  • Single-molecule techniques:

    • FRET to monitor conformational dynamics

    • Optical tweezers to study protein-protein interactions

    • Single-molecule enzymology to detect heterogeneity

    • Super-resolution microscopy for localization studies

  • Advanced -omics integration:

    • Multi-omics approaches combining proteomics, metabolomics, and transcriptomics

    • Temporal analysis throughout viral infection cycle

    • Computational integration to identify functional networks

    • Systems biology modeling of mimivirus-host interactions

These technologies will enable researchers to overcome current limitations in understanding this enigmatic viral protein and place it within its biological context .

How might MIMI_L532 inform novel biotechnological applications?

The unique evolutionary position and properties of MIMI_L532 suggest several biotechnological applications:

  • Novel biocatalysis:

    • Potential for unusual reaction chemistry

    • Ability to function in extreme conditions

    • Evolutionary distinct active site configurations

    • Applications in pharmaceutical or fine chemical synthesis

  • Protein engineering foundations:

    • Minimal P450 scaffolds for designer enzymes

    • Novel substrate recognition patterns

    • Potential oxygen-independent reaction chemistry

    • Fusion protein designs incorporating viral elements

  • Antiviral development insights:

    • Understanding of unique viral enzymes for targeted inhibition

    • Structure-based drug design targeting viral metabolism

    • Broad-spectrum approaches for giant virus inhibition

    • Selective targeting of viral vs. host P450 systems

  • Potential applications matrix:

    Application AreaTechnology ReadinessCompetitive AdvantageResearch Investment Required
    BiocatalysisLow-MediumNovel chemistry potentialHigh
    BiosensorsLowUnique substrate specificityMedium
    Protein engineeringMediumEvolutionary distinct scaffoldMedium
    Antiviral researchMediumNew therapeutic targetMedium-High

The unusual evolutionary history and potential novel functions of MIMI_L532 provide opportunities to develop biotechnologies that exploit its unique properties .

What interdisciplinary collaborations would most benefit MIMI_L532 research?

Advancing MIMI_L532 research requires strategic interdisciplinary collaborations:

  • Structural biology and biochemistry:

    • Expertise in membrane protein expression and purification

    • Advanced spectroscopic characterization

    • Protein crystallography and cryo-EM capabilities

    • Enzyme kinetics and mechanistic studies

  • Virology and host-pathogen interactions:

    • Mimivirus replication cycle expertise

    • Amoeba biology and culturing

    • Viral genetics and genome editing tools

    • Host-pathogen interaction models

  • Computational biology and bioinformatics:

    • Phylogenetic analysis of viral P450s

    • Molecular dynamics simulations

    • Systems biology modeling

    • Artificial intelligence approaches to function prediction

  • Evolutionary biology:

    • Ancient protein reconstruction

    • Horizontal gene transfer analysis

    • Molecular clock studies

    • Origin of viral genes expertise

  • Proposed collaborative research framework:

    DisciplineKey ContributionIntegration Point
    Structural BiologyProtein characterizationFunction prediction
    VirologyIn vivo contextBiological relevance
    Computational BiologyPredictive modelsExperimental design
    Evolutionary BiologyEvolutionary contextOrigin of function
    Synthetic BiologyExpression systemsFunctional testing

A coordinated interdisciplinary approach would address the multifaceted challenges of MIMI_L532 research and place findings in broader biological context .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.